Marquette Asset Management, LLC Spruce Biosciences, Inc. Transaction History

Marquette Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$1.15 - $3.17 $14,489 - $39,942	-12,600 Reduced 18.43%	55,757 $123,000
Q4 2022 Jan 12, 2023	BUY	$0.99 - $1.43 $4,224 - $6,101	4,267 Added 6.66%	68,357 $0
Q2 2022 Jul 15, 2022	BUY	$1.28 - $2.23 $29,743 - $51,818	23,237 Added 56.88%	64,090 $112,000
Q4 2021 Jan 19, 2022	BUY	$2.33 - $5.74 $95,187 - $234,496	40,853 New	40,853 $182,000

15.9M

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.9M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Marquette Asset Management, LLC with notifications on news.